December 2015

Progress in cardiovascular disease-related deaths, but more can be done ()
FDA approves oral medication to treat PAH ()
PwC identifies 10 healthcare issues to look for in 2016 ()
Acute kidney injury is common in patients undergoing vascular surgery ()
Watchman device may be cost-effective, but more research is needed ()
USPSTF recommends statin use for adults at increased risk for cardiovascular disease ()
FDA approves Biotronik ICD systems for use with MRI scans ()
The Year in Review: PCSK9 inhibitors, FDA approvals and deals aplenty ()
Ohio cardiologist is sentenced to 20 years for overbilling ()
Model finds Watchman device is more cost-effective than warfarin and oral anticoagulants ()
FDA approves LifeVest wearable cardioverter defibrillator for children ()
Heart researcher has seventh retraction ()
ACC launches data registry for left atrial appendage occlusion devices ()
Cardiovascular disease-related deaths decline but remain leading cause of death in U.S. ()
FDA removes REMS labeling from rosiglitazone-containing type 2 diabetes medications ()
Cardiac Dimensions appoints new CEO and President ()
Women with type 2 diabetes may have worse cardiovascular outcomes than men ()
FDA advisory committee rejects Merck’s claims that drug reduces risk of CV events ()
ACC, AHA recommend shared decision-making for lipid performance measures ()
Medtronic increases cash dividend for the third quarter of fiscal year 2016 ()
Cardiovascular disease clinical trials often exclude patients with kidney disease ()
ACC, SCAI, HRS release consensus statement on left atrial appendage occlusion requirements ()
When every second counts: Mobile stroke unit performs well in study ()
Society of Thoracic Surgeons releases CABG guidelines ()
Providers outside the U.S. consider Cerner more than any other EMR vendor ()
Boston Scientific voluntarily recalls the Chariot guiding sheath ()
Low adherence rates to cholesterol lowering medications may lead to health, cost concerns ()
University of Washington to Lead U.S. Expansion of Medtronic's HeartRescue Project ()
Renal dysfunction before CABG increases costs and healthcare utilization ()
New reCover Solution Enables IHS Hospitals to Increase Revenue ()
Predicting 30-day readmissions for heart failure patients remains challenging ()
Nearly half of U.S. adults eligible for cholesterol-lowering treatment do not take medications ()
Registry provides real world data on TAVR procedures ()
Patients taking sacubitril/valsartan to treat heart failure may experience survival benefit ()
ACC, Geisinger launch heart failure strategic initiative ()
Medtronic’s revenue increases, net income declines in 2Q of fiscal year 2016 ()
Rate of adults with high total cholesterol declines in U.S. ()
Hospitals, health systems receive prestigious cardiovascular honor ()
ACC and STS release data on TAVR procedures in the U.S. from 2012 to 2014 ()
Cardiologist writes about the future of medicine ()
FDA approves thrombectomy catheter to treat deep vein thrombosis ()